Do temperature and time matter in cold agglutinin disease? von Röth, Alexander

Volltext

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting von Jäger, Ulrich, Barcellini, Wilma, Broome, Catherine M., Gertz, Morie A., Hill, Anita, Hill, Quentin A., Jilma, Bernd, Kuter, David J., Michel, Marc, Montillo, Marco, Röth, Alexander, Zeerleder, Sacha S., Berentsen, Sigbjørn

Volltext

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria von Hillmen, Peter, Szer, Jeff, Weitz, Ilene, Röth, Alexander, Höchsmann, Britta, Panse, Jens, Usuki, Kensuke, Griffin, Morag, Kiladjian, Jean-Jacques, de Castro, Carlos, Nishimori, Hisakazu, Tan, Lisa, Hamdani, Mohamed, Deschatelets, Pascal, Francois, Cedric, Grossi, Federico, Ajayi, Temitayo, Risitano, Antonio, de la Tour, Régis Peffault

Volltext

Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia von Baerlocher, Gabriela M, Oppliger Leibundgut, Elisabeth, Ottmann, Oliver G, Spitzer, Gary, Odenike, Olatoyosi, McDevitt, Michael A, Röth, Alexander, Daskalakis, Michael, Burington, Bart, Stuart, Monic, Snyder, David S

Volltext

Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry von Schrezenmeier, Hubert, Röth, Alexander, Araten, David J., Kanakura, Yuzuru, Larratt, Loree, Shammo, Jamile M., Wilson, Amanda, Shayan, Gilda, Maciejewski, Jaroslaw P.

Volltext

Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria von Kelly, Richard J, Höchsmann, Britta, Szer, Jeff, Kulasekararaj, Austin, de Guibert, Sophie, Röth, Alexander, Weitz, Ilene C, Armstrong, Elina, Risitano, Antonio M, Patriquin, Christopher J, Terriou, Louis, Muus, Petra, Hill, Anita, Turner, Michelle P, Schrezenmeier, Hubert, Peffault de Latour, Regis

Volltext

Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma von Korfel, Agnieszka, Thiel, Eckhard, Martus, Peter, Möhle, Robert, Griesinger, Frank, Rauch, Michael, Röth, Alexander, Hertenstein, Bernd, Fischer, Thomas, Hundsberger, Thomas, Mergenthaler, Hans G, Junghan, Christian, Birnbaum, Tobias, Fischer, Lars, Jahnke, Kristoph, Herrlinger, Ulrich, Roth, Patrick, Bamberg, Michael, Pietsch, Torsten, Weller, Michael

Volltext

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria von Röth, Alexander, Nishimura, Jun-ichi, Nagy, Zsolt, Gaàl-Weisinger, Julia, Panse, Jens, Yoon, Sung-Soo, Egyed, Miklos, Ichikawa, Satoshi, Ito, Yoshikazu, Kim, Jin Seok, Ninomiya, Haruhiko, Schrezenmeier, Hubert, Sica, Simona, Usuki, Kensuke, Sicre de Fontbrune, Flore, Soret, Juliette, Sostelly, Alexandre, Higginson, James, Dieckmann, Andreas, Gentile, Brittany, Anzures-Cabrera, Judith, Shinomiya, Kenji, Jordan, Gregor, Biedzka-Sarek, Marta, Klughammer, Barbara, Jahreis, Angelika, Bucher, Christoph, Peffault de Latour, Régis

Volltext

Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria von Hillmen, Peter, Muus, Petra, Röth, Alexander, Elebute, Modupe O., Risitano, Antonio M., Schrezenmeier, Hubert, Szer, Jeffrey, Browne, Paul, Maciejewski, Jaroslaw P., Schubert, Jörg, Urbano‐Ispizua, Alvaro, Castro, Carlos, Socié, Gérard, Brodsky, Robert A.

Volltext

Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results von Roth, Alexander, Barcellini, Wilma, D'Sa, Shirley, Miyakawa, Yoshitaka, Broome, Catherine M, Michel, Marc, Kuter, David J, Jilma, Bernd, Tvedt, Tor Henrik Anderson, Weitz, Ilene C, Patel, Parija, Jiang, Xiaoyu, Reuter, Caroline, Su, Jun, Shafer, Frank, Lee, Michelle, Berentsen, Sigbjorn

Volltext

The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria von Hillmen, Peter, Young, Neal S, Schubert, Jörg, Brodsky, Robert A, Socié, Gerard, Muus, Petra, Röth, Alexander, Szer, Jeffrey, Elebute, Modupe O, Nakamura, Ryotaro, Browne, Paul, Risitano, Antonio M, Hill, Anita, Schrezenmeier, Hubert, Fu, Chieh-Lin, Maciejewski, Jaroslaw, Rollins, Scott A, Mojcik, Christopher F, Rother, Russell P, Luzzatto, Lucio

Volltext

Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double‐blind, placebo‐controlled, global study (FORWARD) von Kuter, David J., Piatek, Caroline, Röth, Alexander, Siddiqui, Asif, Numerof, Robert P., Dummer, Wolfgang

Volltext

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial von Thiel, Eckhard, Prof, Korfel, Agnieszka, MD, Martus, Peter, Prof, Kanz, Lothar, Prof, Griesinger, Frank, MD, Rauch, Michael, MD, Röth, Alexander, MD, Hertenstein, Bernd, MD, von Toll, Theda, MD, Hundsberger, Thomas, MD, Mergenthaler, Hans-Günther, MD, Leithäuser, Malte, MD, Birnbaum, Tobias, MD, Fischer, Lars, MD, Jahnke, Kristoph, MD, Herrlinger, Ulrich, MD, Plasswilm, Ludwig, MD, Nägele, Thomas, MD, Pietsch, Torsten, Prof, Bamberg, Michael, Prof, Weller, Michael, Prof

Volltext

No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab von Alashkar, Ferras, Rottinghaus, Scott, Vance, Colin, Herich-Terhürne, Dörte, Dührsen, Ulrich, Assert, Roland, Röth, Alexander

Volltext

Immune Activation in Patients With Irritable Bowel Syndrome von Liebregts, Tobias, Adam, Birgit, Bredack, Christoph, Röth, Alexander, Heinzel, Susanne, Lester, Sue, Downie–Doyle, Sarah, Smith, Eric, Drew, Paul, Talley, Nicholas J, Holtmann, Gerald

Volltext

Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without gra... von Tichelli, André, de Latour, Régis Peffault, Passweg, Jakob, Knol-Bout, Cora, Socié, Gérard, Marsh, Judith, Schrezenmeier, Hubert, Höchsmann, Britta, Bacigalupo, Andrea, Samarasinghe, Sujith, Rovó, Alicia, Kulasekararaj, Austin, Röth, Alexander, Eikema, Dirk-Jan, Bosman, Paul, Bader, Peter, Risitano, Antonio, Dufour, Carlo

Volltext

Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria von Peipert, John Devin, Kulasekararaj, Austin G., Gaya, Anna, Langemeijer, Saskia M. C., Yount, Susan, Gonzalez-Fernandez, F. Ataulfo, Ojeda Gutierrez, Emilio, Martens, Christa, Sparling, Amy, Webster, Kimberly A., Cella, David, Tomazos, Ioannis, Ogawa, Masayo, Piatek, Caroline I., Wells, Richard, Sicre de Fontbrune, Flore, Röth, Alexander, Mitchell, Lindsay, Hill, Anita, Kaiser, Karen

Volltext

Cold agglutinin disease: current challenges and future prospects von Berentsen, Sigbjørn, Röth, Alexander, Randen, Ulla, Jilma, Bernd, Tjønnfjord, Geir E

Volltext

Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives von Aramayo-Singelmann, Carmen, Halimeh, Susan, Proske, Pia, Vignalingarajah, Abinuja, Cario, Holger, Christensen, Morten O., Yamamoto, Raina, Röth, Alexander, Reinhardt, Dirk, Reinhardt, Hans Christian, Alashkar, Ferras

Volltext

Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat von Oppliger Leibundgut, Elisabeth, Haubitz, Monika, Burington, Bart, Ottmann, Oliver G, Spitzer, Gary, Odenike, Olatoyosi, McDevitt, Michael A, Röth, Alexander, Snyder, David S, Baerlocher, Gabriela M

Volltext